FASN and hepatocellular carcinoma: Overall, our data indicate that elevated levels of both active c-MYC and FASN gene are predictors of poor prognosis in this aggressive tumor, and suggest the functional interplay between c-MYC and FASN also in human HCC, as demonstrated in in vitro and in vivo models.